ATE102249T1 - Modulaerer zusammenbau von antikoerpergenen, dadurch hergestellte antikoerper und deren anwendung. - Google Patents

Modulaerer zusammenbau von antikoerpergenen, dadurch hergestellte antikoerper und deren anwendung.

Info

Publication number
ATE102249T1
ATE102249T1 AT88907510T AT88907510T ATE102249T1 AT E102249 T1 ATE102249 T1 AT E102249T1 AT 88907510 T AT88907510 T AT 88907510T AT 88907510 T AT88907510 T AT 88907510T AT E102249 T1 ATE102249 T1 AT E102249T1
Authority
AT
Austria
Prior art keywords
antibodies
applications
genes
modular assembly
produced
Prior art date
Application number
AT88907510T
Other languages
English (en)
Inventor
Randy R Robinson
Alvin Y Liu
Arnold H Horwitz
Randolph Wall
Marc Better
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Priority claimed from EP88907510A external-priority patent/EP0371998B2/de
Application granted granted Critical
Publication of ATE102249T1 publication Critical patent/ATE102249T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
AT88907510T 1987-07-24 1988-07-25 Modulaerer zusammenbau von antikoerpergenen, dadurch hergestellte antikoerper und deren anwendung. ATE102249T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7752887A 1987-07-24 1987-07-24
EP88907510A EP0371998B2 (de) 1987-07-24 1988-07-25 Modulärer zusammenbau von antikörpergenen, dadurch hergestellte antikörper und deren anwendung
PCT/US1988/002514 WO1989000999A1 (en) 1987-07-24 1988-07-25 Modular assembly of antibody genes, antibodies prepared thereby and use

Publications (1)

Publication Number Publication Date
ATE102249T1 true ATE102249T1 (de) 1994-03-15

Family

ID=26119480

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88907510T ATE102249T1 (de) 1987-07-24 1988-07-25 Modulaerer zusammenbau von antikoerpergenen, dadurch hergestellte antikoerper und deren anwendung.

Country Status (1)

Country Link
AT (1) ATE102249T1 (de)

Similar Documents

Publication Publication Date Title
ATE74126T1 (de) D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.
DE3670477D1 (de) Zusammensetzungen von sprengstoffemulsionen und deren herstellung.
DE3888040D1 (de) Transformation von Sojabohnenpflanzen und Zellinien mit Hilfe von Partikeln.
DE68920223D1 (de) Enzymelektroden und ihre Herstellung.
DE3687646D1 (de) Biosensor und dessen herstellung.
DE68924026D1 (de) Biosensor und dessen herstellung.
DE3579888D1 (de) Carbapenemverbindungen und deren herstellung.
DE69010800D1 (de) Herstellung von Polymere Metalloxyd-Werkstoffe.
DE3884453D1 (de) Homogene additionscopolymere von ethylen und cycloolefinmonomeren und deren herstellung.
DE3874495D1 (de) Elektrodenkatalysator und dessen herstellungsverfahren.
DE3888146D1 (de) Modifizierte Polytetrafluoräthylenharze und damit hergestellte Zusammensetzungen.
ATE40365T1 (de) 3-acylaminomethylimidazo (1,2-a> pyridine, dessen herstellung und therapeutische anwendung.
DE3484473D1 (de) Chroman-verbindungen und deren herstellung.
DE68908313D1 (de) Klebverbaende, ihre herstellung und anwendung.
DE68917352D1 (de) Trimethylolheptane und ihre Anwendung.
DE3579807D1 (de) Antibiotische gebundene prothesen und deren herstellung.
DE3577842D1 (de) Herstellungsverfahren von stearyl-beta-(3,5-dibutyl-4-hydroxyphenyl)propionat und bis-beta-(3,5-dibutyl-4-hydroxybenzyl)-methyl-karboxyaethyl sulfid.
DE3671426D1 (de) Dipropargyloxybenzolverbindungen und deren herstellung.
DE3771623D1 (de) Zusammengesetzte schutzstoffe, deren erzeugung und daraus hergestellte gegenstaende.
DE3786934D1 (de) Halbleiterlaser von eingebettetem struktur-typ und dessen herstellungsverfahren.
DE68906992D1 (de) Indanylring enthaltende pyrethinester, deren herstellung und deren anwendung als pestizide.
DE3885384D1 (de) Organosilikonverbindungen, deren Herstellung und Anwendung.
ATE96142T1 (de) Triglyceridquartaerammonium-verbindungen, ihre herstellung und anwendung.
ATE102249T1 (de) Modulaerer zusammenbau von antikoerpergenen, dadurch hergestellte antikoerper und deren anwendung.
DE3671823D1 (de) Nagetierabwehrende mikrokapseln und deren herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time